Ishares Trust · net assets $191M · 61 holdings as of July 31, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 87.0% · STIV: 9.5% · OTHER: 3.5% · DE: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $0 | $9.74M | $5.05M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $0 | $0 | $0 |
| Net realized gain (non-derivative) | $-98.7 | $3.16M | $-824 |
| Net unrealized appreciation (non-derivative) | $2.34M | $18.1M | $-7.71M |
The three months of the reporting period, as filed; month 3 ends July 31, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Blackrock Funds Iii: Blackrock Cash Funds: Institutional; Sl Agency Shares STIV | $19.8M | 10.39% |
| Bayer Aktiengesellschaft EC | $9.18M | 4.81% |
| Twist Bioscience Corp EC | $9.15M | 4.79% |
| Revolution Medicines, Inc. EC | $8.69M | 4.55% |
| Regeneron Pharmaceuticals, Inc. EC | $8.3M | 4.35% |
| Genmab A/s EC | $8.08M | 4.23% |
| Incyte Corporation EC | $8.08M | 4.23% |
| Moderna, Inc. EC | $7.99M | 4.19% |
| Takeda Pharmaceutical Company Limited EC | $7.73M | 4.05% |
| Merck & Co., Inc. EC | $7.46M | 3.91% |
| Vertex Pharmaceuticals Incorporated EC | $7.39M | 3.87% |
| Roche Holding Ag EC | $7.34M | 3.85% |
| Ipsen Sa EC | $7.33M | 3.84% |
| Biontech Se OTHER | $7.11M | 3.73% |
| Exelixis, Inc. EC | $6.96M | 3.65% |
| Gsk PLC EC | $6.93M | 3.63% |
| Sanofi Sa EC | $6.61M | 3.46% |
| Ideaya Biosciences Inc EC | $6.41M | 3.36% |
| Immunitybio Inc EC | $5.86M | 3.07% |
| Arcus Biosciences, Inc. EC | $5.12M | 2.68% |
| Caris Life Sciences, Inc. EC | $4.17M | 2.18% |
| Ono Pharmaceutical Co., Ltd. EC | $3.65M | 1.91% |
| Iovance Biotherapeutics Inc EC | $3.43M | 1.80% |
| Nuvation Bio Inc. EC | $3.39M | 1.78% |
| Crispr Therapeutics Ag EC | $2.99M | 1.57% |
| Abcellera Biologics Inc. EC | $2.91M | 1.52% |
| Vir Biotechnology Inc EC | $2.51M | 1.31% |
| Novavax, Inc. EC | $2.49M | 1.30% |
| Janux Therapeutics Inc EC | $1.88M | 0.99% |
| Sunshine Lake Pharma Co Ltd EC | $1.87M | 0.98% |
| Corvus Pharmaceuticals Inc EC | $1.82M | 0.95% |
| Personalis Inc EC | $1.7M | 0.89% |
| Kura Oncology Inc EC | $1.68M | 0.88% |
| Genfleet Therapeutics (shanghai) Inc EC | $1.48M | 0.78% |
| Rigel Pharmaceuticals, Inc. EC | $1.43M | 0.75% |
| Cytomx Therapeutics Inc EC | $1.17M | 0.61% |
| Verastem, Inc. EC | $1.04M | 0.54% |
| Alvotech Sa EC | $1.01M | 0.53% |
| Design Therapeutics Inc EC | $996K | 0.52% |
| Xencor Inc EC | $984K | 0.52% |
| Intellia Therapeutics, Inc. EC | $981K | 0.51% |
| Shanghai Henlius Biotech Inc EC | $964K | 0.51% |
| Ocugen, Inc. EC | $890K | 0.47% |
| Pacific Biosciences Of California, Inc. EC | $871K | 0.46% |
| Valneva Se EC | $866K | 0.45% |
| Ginkgo Bioworks Holdings Inc EC | $820K | 0.43% |
| Abclon Inc. EC | $470K | 0.25% |
| Prime Medicine, Inc EC | $191K | 0.10% |
| Blackrock Funds Iii: Blackrock Cash Funds: Treasury; Sl Agency Shares STIV | $178K | 0.09% |
| Japanese Yen OTHER | $71.6K | 0.04% |
| Great British Pound OTHER | $58.4K | 0.03% |
| Xav Health Care Sep26 DE | $25.7K | 0.01% |
| Korean Won OTHER | $14.9K | 0.01% |
| Danish Kroner OTHER | $13.7K | 0.01% |
| Arcellx Inc Cvr EC | $5.11K | 0.00% |
| Hong Kong Dollar OTHER | $3.68K | 0.00% |
| Swiss Franc OTHER | $860 | 0.00% |
| Euro OTHER | $763 | 0.00% |
| New Taiwan Dollar OTHER | $162 | 0.00% |
| Omniab Inc EC | $0.19 | 0.00% |
Showing top 60 of 61 holdings.
Loading...
